Today’s AI Top Pick: DUOL

9/30/2026 · Highly Shorted Short-Term Bounce 🧪Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured 4-hour model accuracy · DUOL68%529 resolved forecasts · 30d window · verify →

View the live DUOL price forecast →

Today's pick · Highly Shorted Short-Term Bounce 🧪Deep RotationDUOLBUY NOW8.5 / 109/30/2026

Duolingo is the only candidate that satisfies the full multi-timeframe agreement requirement. On the 1-hour and 1-week charts the forecast vectors are uniformly positive (fc_short 1.06%/1.15%, fc_mid 0.92%/25.69%, fc_long 0.89%/35.20%), and critically the 1-week tape is up 26.54% over the last 21 bars with the price sitting at 73.54% of its range — a healthy, confirmed uptrend rather than a stretched top. The 4-hour shows a mild -1.85% pullback with price at 44.31% of range (near the middle, not chasing), and the 1-day is down -9.95% off its 21-bar high with price at only 35.36% of range — a deep, attractive re-entry point after a sharp dip. This is exactly the 'short-term lean negative but multi-timeframe agreeing' setup the lens is designed to catch: the daily weakness is a pullback within a confirmed weekly uptrend, not a broken trend. Fundamentally DUOL is the strongest name in the pool by a wide margin. It posts 34.42% ROE, 35.87% profit margin, 72.22% gross margin, and 29.36% year-over-year sales growth — all excellent for a $6.67B company trading at a 17.1x trailing P/E (forward P/E 42.5x reflects the expected earnings recovery). Short float of 16.54% clears the ≥15% screen and provides a squeeze runway into the bounce. The fundamental_score of +3.25 is the highest of the three, and analyst consensus (recom 2.7) is constructive. News is a clean tailwind, not a landmine. Schaeffer's flagged a 'historically bullish' setup on 2026-09-29, and the American Banking News/Coursera comparisons are neutral-to-positive peer positioning. No guidance cuts, dilution, or short-seller reports. Today's entry is justified because price is at the low-mid of its 21-bar range on both the daily and 4-hour timeframes after a ~10% daily drawdown — you are buying strength that has already re-coiled, not chasing an extended bar. RUM and TEM both fail on trend confirmation despite passing the screen on paper.

DUOL forecast chart
Entry zone
Buy 141.80-143.00 (current ~142.97 on 1d; 141.80 on 1h/4h/1wk). Add on any dip toward 138-140 if the daily re-accelerates.
Stop loss
Close below 135.50 (below the 21-bar low cluster; invalidates the weekly re-entry thesis).
First target
152-155 (retest of the 21-bar high area on daily recovery)
Longer target
168-172 (prior structure/weekly trend extension)
Risks
  • Forward P/E of 42.5x implies earnings must recover sharply; any miss on the 29% growth trajectory could compress the multiple.
  • Daily trend still negative (-9.95% over 21 bars) — a failed bounce could re-test lower support quickly.
  • 16.54% short float is a double-edged sword: squeeze upside but also means elevated short-seller attention and volatility.
  • Bullish probability sits at only 0.40 (below the 0.55 meaningful threshold), signaling the model is not yet fully convinced.
  • YTD performance -18.74% and -56.62% over the past year show a fragile longer-term trend that could reverse on market-wide risk-off.
Honorable mentions
RUM#2 pick: 21.57% short float clears the screen and a $13B Anthropic deal triggered a 94%-upside analyst re-rating (2026-09-30), a strong narrative catalyst. But fundamentals are broken (ROE -19.18%, profit margin -134.6%, operating margin -100.96%) and the 4h/1wk show price at 0% and 57.47% of range with no clean multi-timeframe up-agreement, so it's a higher-variance speculative play rather than a confident buy.
TEM#3 pick: strongest positive catalyst (FDA 510(k) clearance for ECG-MR AI product, 2026-09-28) and 25.94% short float. However, it fails the trend-agreement test — fc_mid and fc_long are deeply negative (-27.41%/-20.16% on 1d, -10.59%/-29.81% on 1wk), price is at 87-95% of its 21-bar range (chasing), and fundamentals are poor (ROE -67.44%, fwd P/E 3264x, negative margins). Fundamental_score of -5 is the worst of the group.
Full ranking (3)
#SymbolVerdictScoreRead
1DUOLBUY NOW8.5Only name with full multi-timeframe up-agreement, deep daily re-entry point, and strong fundamentals (34% ROE, 29% growth, 17x P/E) plus clean news tailwind.
2RUMBUY PULLBACK4.2Anthropic-driven 94%-upside catalyst and 21.57% short float, but broken margins and no clean trend agreement make it speculative.
3TEMWAIT3.0FDA clearance is a real catalyst and short float is high, but price is at the top of its range with negative mid/long forecasts and terrible fundamentals.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.